Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95

Lancet

Volumn 351, Issue 9109, 1998, Pages 1081-1085

  Van Duijn, C M ^a   Delasnerie Laupretre N ^b   Masullo, C ^c   Zerr, I ^d   De Silva, R ^e   Wientjens, D P W M ^a   Brandel, J P ^b   Weber, T ^f   Bonavita, V ^g   Zeidler, M ^e   Alperovitch A ^b   Poser, S ^d   Granieri, E ^h   Hofman, A ^a   Will, R G ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

^f Marienkrankenhaus   (Germany)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERTILIZER;

ADULT; AGED; ARTICLE; BELGIUM; BRAIN; CASE CONTROL STUDY; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DIET; EUROPE; EUROPEAN UNION; EXPOSURE; FEMALE; FRANCE; GERMANY; HEREDITY; HUMAN; ITALY; LEATHER INDUSTRY; MAJOR CLINICAL STUDY; MALE; MEAT; NETHERLANDS; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

EID: 0002190768     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)09468-3     Document Type: Article

References (27)

1. 1 Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol 1994; 35: 385-95.
2. 2 Brown P, Cazthala F, Raubertas RF, Gajdusek D, Vastaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987; 37: 895-904.
3. 3 Will RG, Alpérovitch A, Poser S, et al. Creutzfeldt-Jakob disease in Europe 1993-1995. Ann Neurol (in press).
4. 4 Anderson RM, Donnelly CA, Ferguson NM, et al. Transmission dynamics and epidemiology of BSE in British Cattle. Nature 1996; 382: 779-88.
5. 5 Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-25.
6. 6 Powell-Jackson J, Weller R, Kennedy P, et al. Creutzfeldt-Jakob disease following human growth hormone administration. Lancet 1985; 2: 244-46.
7. 7 Gibbs C, Joy A, Heffner R, et al. Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 1985; 313: 734-39.
8. 8 Brown P, Gajdusek DG, Gibbs CJ, Asher DM. Potential epidemic of Creutzfeldt-Jakob disease from human growth hormone therapy. N Engl J Med 1985; 313: 728-31.
9. 9 Cochius JI, Mack K, Burns RJ, Alderman CP, Blumbergs PC. Creutzfeldt-Jakob disease in a recipient of human pituitary gonadotrophin. Austr N Z J Med 1990; 20: 592-93.
10. 10 Masters CL, Richardson EP Jr. Subacute spongiform encephalopathy Creutzfeldt-Jakob disease: the nature and progression of spongiform change. Brain 1978; 101: 333-44.
11. 11 Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982; 45: 235-38.
12. 12 Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. J Neurosurg 1988; 69: 766-69.
13. 13 Bernouilli C, Siegfried J, Baumgartner G, et al. Danger of accidental person to person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1: 478-79.
14. 14 Duffy P, Wolf J, Collins G, et al. Possible person to person transmission of Creutzfeldt-Jakob disease. N Engl J Med 1974; 290: 692-93.
15. 15 Wientjens DPWM, Davanipour Z, Hofman A, et al. Risk factors for Creutzfeldt-Jakob disease: a re-analysis of case-control studies. Neurology 1996; 46: 1287-91.
16. 16 Manuelidis E, Kim JH, Mericangas J, Manuelidis L. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985; ii: 896-97.
17. 17 Tateishi J. Transmission of Creutzfeldt-Jakob disease from human blood and urine into mice. Lancet 1985; ii: 1074.
18. 18 Masters CL, Haoris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979; 5: 177-88.
19. 19 Schlesselman JL. Case-control studies. New York: Oxford University Press, 1982.
20. 20 Collinge J, Palmer MS, Dryden AJ. Genetic prediposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-42.
21. 21 Palmer MS, Dry den AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-41.
22. 22 Laplanche JL, Delasnerie-Lauprêtre N, Brandel JP, et al. Molecular genetics of prion disease in France. Neurology 1994; 44: 2347-51.
23. 23 Salvatore M, Genuardi M, Petravoli R, et al. Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum Genet 1994; 94: 375-79.
24. 24 Windl O, Dempster M, E Stibeiro JP, et al. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in PRNP gene. Hum Genet 1996; 98: 259-64.
25. 25 Smith PG, Day NE. The design of case-control studies: the influence of confounding and interaction effects. Int J Epidemiol 1984; 13: 356-65.
26. 26 National CJD Surveillance Unit, Department of Epidemiology & Population Sciences. Creutzfeldt-Jakob disease surveillance in the United Kingdom. Fourth annual report, 1995.
27. 27 van Duijn CM, Clayton D, Chandra V, et al. Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991; 20: S13-S20.